GLP-one course compounds. Semaglutide, tirzepatide, and liraglutide are authorised medicinal products during the Netherlands and carry elevated regulatory and import scrutiny. Any framing that offers them as therapeutic options to prescription medicines provides them under the Geneesmiddelenwet and